Innovation Pharmaceuticals Inc Quick Ratio (CTIX) starting from the first quarter 2023 to first quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Innovation Pharmaceuticals Inc   (CTIX)

Innovation Pharmaceuticals Inc 's Quick Ratio

CTIX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the first quarter 2023, Quick Ratio fell to 0.19 below Innovation Pharmaceuticals Inc average.

Within Major Pharmaceutical Preparations industry 512 other companies have achieved higher Quick Ratio than Innovation Pharmaceuticals Inc in first quarter 2023. While Quick Ratio total ranking in the first quarter 2023 has deteriorated compared to the prior quarter from 2831 to 3762.

Explain Quick Ratio?
How much Cash & cash equivalents CTIX´s has?
What are CTIX´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CTIX Quick Ratio (Sep 30 2023)
Q1		 (Jun 30 2023)
Q4		 (Mar 31 2023)
Q3		 (Dec 31 2022)
Q2		 (Sep 30 2022)
Q1
Y / Y Current Liabilities Change -1.62 % 4.43 % 4.99 % 7.41 % -17.6 %
Y / Y Cash & cash equivalent Change -69.07 % -58.92 % -77.26 % -74.99 % -73.01 %
Quick Ratio MRQ 0.19 0.32 0.42 0.52 0.59
CTIX's Total Ranking # 3762 # 2831 # 2873 # 1143 # 2528
Seq. Current Liabilities Change 0.54 % 4.17 % -0.08 % -5.98 % 6.72 %
Seq. Cash & cash equivalent Change -40.98 % -20.91 % -19.31 % -17.89 % -21.6 %



Quick Ratio first quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 513
Healthcare Sector # 1003
Overall Market # 3762


Quick Ratio Statistics
High Average Low
2.23 0.63 0
(Dec 31 2021)   (Jun 30 2012)




Financial Statements
Innovation Pharmaceuticals Inc 's Current Liabilities $ 5 Millions Visit CTIX's Balance sheet
Innovation Pharmaceuticals Inc 's Cash & cash equivalent $ 1 Millions Visit CTIX's Balance sheet
Source of CTIX's Sales Visit CTIX's Sales by Geography


Cumulative Innovation Pharmaceuticals Inc 's Quick Ratio

CTIX's Quick Ratio for the trailling 12 Months

CTIX Quick Ratio

 (Sep 30 2023)
12 Months		 (Jun 30 2023)
12 Months		 (Mar 31 2023)
12 Months		 (Dec 31 2022)
12 Months		 (Sep 30 2022)
12 Months
Y / Y Current Liabilities TTM Growth 3.64 % -1.6 % -10.36 % -18.27 % -26.8 %
Y / Y Cash & cash equivalent TTM Growth -72.65 % -73.09 % -71.68 % -59 % -39.87 %
Quick Ratio TTM 0.36 0.46 0.58 0.95 1.36
Total Ranking TTM # 4014 # 3998 # 4196 # 679 # 3681
Seq. Current Liabilities TTM Growth -0.42 % 1.09 % 1.18 % 1.75 % -5.45 %
Seq. Cash & cash equivalent TTM Growth -22.97 % -19.99 % -37.45 % -29.06 % -24.2 %

Quick ratio ranking by company, industry and sector >> Back to CTIX Financial Strength Comparisons >> Go to Compare CTIX Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in CTIX's Current Liabilities to $5.05 millions, cumulative Quick Ratio to 0.36 below the CTIX average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 537 other companies have achieved higher Quick Ratio than Innovation Pharmaceuticals Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2023 from 3998 to 4014.

Explain Quick Ratio?
How much Cash & cash equivalents CTIX´s has?
What are CTIX´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 538
Healthcare Sector # 1084
Within the Market # 4014


trailing twelve months Quick Ratio Statistics
High Average Low
1.89 0.7 0.08
(Dec 31 2021)   (Jun 30 2019)




Companies with similar Quick Ratio in the quarter ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2023 MRQ Cash & cash equivalentSep 30 2023 MRQ Current Liabilities
Dmk Pharmaceuticals Corporation  0.50 $ 6.664  Millions$ 13.399  Millions
Bausch Health Companies Inc   0.50 $ 760.000  Millions$ 1,529.000  Millions
Keenova Therapeutics Plc  0.49 $ 389.800  Millions$ 799.000  Millions
Alimera Sciences Inc  0.47 $ 8.285  Millions$ 17.721  Millions
Contrafect Corporation  0.46 $ 5.413  Millions$ 11.643  Millions
Galapagos Nv  0.46 $ 222.709  Millions$ 479.610  Millions
Prestige Consumer Healthcare Inc   0.46 $ 60.067  Millions$ 129.704  Millions
Nrx Pharmaceuticals Inc   0.46 $ 8.902  Millions$ 19.327  Millions
Elite Pharmaceuticals Inc   0.45 $ 8.675  Millions$ 19.078  Millions
Biophytis Sa  0.45 $ 6.235  Millions$ 13.849  Millions
Vbi Vaccines Inc  0.45 $ 35.454  Millions$ 78.762  Millions
Intercure Ltd   0.45 $ 27.907  Millions$ 62.322  Millions
Evelo Biosciences Inc   0.43 $ 17.262  Millions$ 39.761  Millions
Blue Water Vaccines Inc  0.43 $ 7.654  Millions$ 17.645  Millions
Integrated Biopharma Inc  0.42 $ 2.594  Millions$ 6.197  Millions
Exicure Inc   0.42 $ 0.922  Millions$ 2.221  Millions
Sonnet Biotherapeutics Holdings Inc   0.41 $ 2.274  Millions$ 5.525  Millions
Optinose Inc   0.41 $ 66.845  Millions$ 163.981  Millions
Elanco Animal Health Incorporated  0.41 $ 369.000  Millions$ 909.000  Millions
Societal Cdmo Inc   0.40 $ 8.156  Millions$ 20.524  Millions
Ironwood Pharmaceuticals inc   0.39 $ 110.164  Millions$ 280.579  Millions
Tonix Pharmaceuticals Holding Corp   0.39 $ 6.914  Millions$ 17.733  Millions
Abbvie Inc   0.38 $ 13,290.000  Millions$ 34,773.000  Millions
Lftd Partners Inc   0.38 $ 3.125  Millions$ 8.197  Millions
Merck and Co Inc   0.38 $ 8,773.000  Millions$ 23,094.000  Millions
Earth Science Tech Inc   0.37 $ 0.188  Millions$ 0.509  Millions
Sellas Life Sciences Group Inc   0.36 $ 4.069  Millions$ 11.269  Millions
Kuvatris Therapeutics Inc   0.35 $ 1.153  Millions$ 3.271  Millions
Cingulate Inc   0.35 $ 1.986  Millions$ 5.732  Millions
Bristol myers Squibb Company  0.33 $ 7,839.000  Millions$ 23,462.000  Millions

Date modified: 2026-09-08T15:11:07+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.